THE EVIDENCE

Sensory decline:
triple the dementia risk.

Risk climbs with every sense that declines, and most people never notice. Many of those losses are fixable. Here’s the evidence, and what changes when we act.

THE WORLD WE BUILT

We measure the heart obsessively. The brain’s inputs, almost never.

Most of us know our blood pressure, our cholesterol, our glucose, even our steps and our sleep. Ask when someone last had their smell, hearing, vision, taste or touch measured, and how those have changed over time, and most people can’t say. [21]

TRACKED FOR DECADES

✓ Blood pressure✓ Cholesterol✓ Glucose✓ Steps✓ Sleep

TRACKED OVER TIME, ALMOST NEVER

SmellTasteTouchHearingVision
“Early changes in smell and hearing are often the brain’s first quiet signals that something is shifting. We should be tracking those senses as routinely as blood pressure or cholesterol.”

Dr. Sita Kedia, MD, MPH

Preventive neurology · Chief Medical Officer, PALM Health

THE WAKE-UP CALL

COVID showed the world what losing an input feels like.

401

people scanned before and after infection

Loss of smell and taste became one of the defining symptoms of the pandemic. Then a UK Biobank study that scanned the same people before and after infection found greater loss of gray matter thickness in the orbitofrontal cortex and parahippocampal gyrus, regions tied to smell and memory, plus more tissue damage in areas connected to the primary smell cortex, compared with 384 people who weren’t infected. [22]

WHERE IT STOPS

Mostly mild infections, in adults 51 to 81. Whether these changes last is still being studied.

THE EVIDENCE 1 OF 5 · YOU MAY NOT FEEL IT

Most people whose sense of smell has declined don’t know it.

3 in 4

people with measurable smell decline were unaware of it.

Those who didn’t know had the most cognitive change five years later. National US study, 1,468 adults. [1]

WHERE IT STOPS

Smell only, in adults 57 and over.

ALSO

2x

risk of cognitive decline with poorer smell, across 48 studies and 37,783 people. Cognitive decline, not dementia. [2]

THE EVIDENCE 2 OF 5 · MEASURING CATCHES IT

Measured hearing loss was linked to dementia. Self-reported hearing loss wasn’t.

In a community study of 2,946 adults, 66% had hearing loss on a hearing test, but only 37% said they did. Measured hearing loss was linked with later dementia. Self-reported hearing was not. [3]

Measured on a hearing test

66.1%

Reported by participants

37.2%

Ishak et al. 2025 · ARIC-NCS · 2,946 adults · hearing measured by audiometry vs self-report [3]

WHERE IT STOPS

One US cohort.

ALSO

32%

of new dementia cases in that cohort were tied to measured hearing loss. A statistical estimate, not a promise that treating hearing prevents them. [3]

ALSO

2 of 5

senses are on the Lancet Commission’s list of 14 modifiable dementia risk factors: hearing and vision. Smell, taste and touch aren’t on it. [4]

THE EVIDENCE 3 OF 5 · IT SHOWS UP EARLY

Smell declined while thinking was still normal, and it was linked to who declined later.

OVER TIME

A decline can say more than one low result.

SteadyDrifting downNormal variation

Illustrative, not study data: two people start at the same point and are retested five times.

The fastest smell decline was linked to who would later develop mild cognitive impairment or dementia.

515 adults had their smell tested every year for up to 18 years. Those whose smell declined fastest, while their thinking was still normal, had higher odds of later mild cognitive impairment or dementia (odds ratio 1.89). Their brain scans also showed less gray matter in regions tied to memory. [5]

One result shows where you are. A pattern shows which way you’re going.

WHERE IT STOPS

Smell, in one long-running cohort. No fixed number of years of warning.

ALSO

2.13x

odds of a dementia diagnosis five years later for adults with poor smell. 2,906 adults, adjusted for baseline thinking. [6]

THE EVIDENCE 4 OF 5 · IT COMPOUNDS

Healthy senses:
less than half the dementia risk.

ACROSS SENSES

The more senses impaired, the higher the later dementia risk.

No impairment1.01 sense1.492 senses1.913 or 4 senses2.851.0 reference

Adjusted dementia hazard ratios vs no impairment; lines show 95% confidence intervals. Health ABC · 1,810 adults aged 70 to 79 · 10 years · vision, hearing, smell and touch measured · observational [7]

People whose senses stayed healthy had less than half the dementia risk of people with three or four in decline. One impaired sense: 1.5x. Two: 1.9x. Three or four: 2.85x. Same 1,810 people, followed for 10 years. [7]

Which comes first is still debated. What the data show: the more senses decline, the higher the risk.

And within each sense, it’s a staircase, not a switch.

HEARING

1.9→4.9x

mild → severe

Dementia risk climbs with each step of hearing loss: 1.9x mild, 3.0x moderate, up to 4.9x severe. [8]

VISION

1.3→2.2x

mild → moderate+

Dementia risk by measured visual acuity, 62,206 people. [9] Contrast sensitivity: 9% higher risk per 0.1 lost. [10]

SMELL

1.5→2.6x

moderate → severe

Risk of cognitive decline by severity of smell decline. 48 studies, 37,783 people. [2]

TASTE

Early

no single number yet

Lower in Alzheimer’s and in Parkinson’s with cognitive impairment. Not yet measured by severity. [11]

TOUCH

1.7→2.4x

one sign → three or more

Impaired vibration sense: 1.7x dementia risk. Three or more nerve impairments: 2.4x. 2,174 people, 11 years. [12] Measured at the toe; we test the fingertip.

WHERE IT STOPS

Observational. Each sense’s numbers come from its own study, so they’re never added together.

ALSO

All 5

Across all five, poorer combined function was linked to worse thinking, mobility, independence and survival five years later. 3,005 adults. [13]

ALSO

3.37x

odds of dying within five years for adults who had lost their sense of smell. 2,918 adults. An association, not a cause. [14]

THE EVIDENCE 5 OF 5 · IT’S FIXABLE

Many sensory losses can be fixed. The sooner you catch them, the sooner you can act.

Glasses, cataract surgery, hearing aids and smell training restore what the brain takes in. Cataract surgery, which restores sight, was linked to 29% lower dementia risk. Glaucoma surgery, which doesn’t restore sight, showed no such link. [20] And in a randomized trial of 977 adults aged 70 to 84, restoring hearing slowed cognitive decline in people at higher risk. [15]

THINKING

48% slower

cognitive decline over three years, in the higher-risk group of 238 participants. The full trial showed no significant overall effect. [15]

Randomized trial · ACHIEVE

FALLS

27% fewer

falls on average over three years: 1.45 vs 1.98 reported falls per person. [16]

Randomized trial · ACHIEVE

CONNECTION

+1 person

kept in their social network on average, compared with health education. [17]

Randomized trial · ACHIEVE

RESTORING SIGHT

Half the speed

After cataract surgery, memory declined at about half the speed it had before. [24]

English Longitudinal Study of Ageing, 13-year follow-up

WHERE IT STOPS

Most of this evidence is observational. Catching a change earlier isn’t yet proven to prevent lasting decline. The 48% is the higher-risk group of 238 people; the full trial showed no overall effect. [15] These are results of sensory care, not of SuperSenses.

ALSO

42% → 0

Untreated hearing loss carried 42% higher dementia risk. With hearing aids, the extra risk wasn’t measurable. 437,704 people, observational. [19]

WHAT RESEARCHERS SAY

The people who study the senses are asking for the same thing.

WHY YOUR SENSES MATTER, FROM A SENSORY SCIENTIST

“People who have smell and taste issues need care, just like people who have impairments in our other senses, like sight and hearing.”

Dr. Jonathan Overdevest, MD, PhD

Columbia University

“We’ve underestimated everyday sensory/perceptual change in dementia; aligning rigorous science with practical, scalable tools is the next step.”

Prof. Andrea Tales, PhD

Neuropsychology & Dementia Research, Swansea University.

THE MISSING LAYER

Blood work reads your biology. Cognitive tests read the output. Your senses are the input.

OUTPUT

Cognitive tests

Memory and thinking. Where symptoms show up.

INPUT

Your five senses, measured over time

Smell, taste, touch, hearing and vision. What the brain takes in. This is the layer SuperSenses adds.

BIOLOGY

Blood work and biomarkers

What’s happening in the body’s chemistry.

Together they show the whole picture. The input layer is the one you can measure at home, again and again, and watch change.

WHAT IT UNLOCKS

What changes when we measure the inputs.

FOR COMMUNITIES

A longevity center

Residents measure their senses, act on every result and see what’s working, as part of community life.

FOR CLINICS

An early signal

A view of neurological change alongside the labs and cognitive tests you already run.

FOR EVERYONE

A window, and proof

A window to act early, and proof that what you’re doing for your health is working.

STRAIGHT TALK, FOR THE SCIENTISTS

Most of this research shows links, not proof of cause. The treatment studies come closest, and they’re strongest for hearing. Every number on this page is from one study, stated with its population, and never added to another. SuperSenses doesn’t diagnose. It measures. We wrote this page, and we make sensory tests.

The evidence is in.
The measuring isn’t.

See how SuperSenses measures all five senses on the Science page, or start now.

A sensory result can prompt attention. It does not diagnose dementia or identify its cause.

Sources

1. Adams DR, et al. Factors associated with inaccurate self-reporting of olfactory dysfunction in older US adults. Chem Senses, 2017;42(3):223-231. NSHAP, 1,468 people. doi:10.1093/chemse/bjw108

2. Yeo BSY, et al. Int Forum Allergy Rhinol, 2025;15(12):1347-1358. 48 studies, 37,783 people. doi:10.1002/alr.23635

3. Ishak E, et al. JAMA Otolaryngol Head Neck Surg, 2025. ARIC-NCS, 2,946 people. doi:10.1001/jamaoto.2025.0192

4. Livingston G, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. Lancet, 2024;404:572-628. doi:10.1016/S0140-6736(24)01296-0

5. Pacyna RR, et al. 2023. 515 people tested annually, up to 18 years. pubmed.ncbi.nlm.nih.gov/35899859

6. Adams DR, Pinto JM, et al. 2018. NSHAP, 2,906 adults, five-year follow-up. pubmed.ncbi.nlm.nih.gov/28944467

7. Brenowitz WD, Kaup AR, Lin FR, Yaffe K. Multiple sensory impairment is associated with increased risk of dementia among Black and White older adults. J Gerontol A Biol Sci Med Sci, 2019;74(6):890-896. Health ABC, 1,810 people. doi:10.1093/gerona/gly264

8. Lin FR, et al. Hearing loss and incident dementia. Arch Neurol, 2011;68(2):214-220. BLSA, 639 people, median 11.9 years. doi:10.1001/archneurol.2010.362

9. Littlejohns TJ, Hayat S, Luben R, et al. Visual impairment and risk of dementia in two population-based prospective cohorts: UK Biobank and EPIC-Norfolk. J Gerontol A Biol Sci Med Sci, 2022. 62,206 people. doi:10.1093/gerona/glab325

10. Almidani L, et al. Am J Ophthalmol, 2024. NHATS, 2,159 people.

11. Mantovani E, Zanini A, Cecchini MP, Tamburin S. Neuropsychol Rev, 2024;34:192-213. doi:10.1007/s11065-023-09578-3

12. Brenowitz WD, Robbins NM, Strotmeyer ES, Yaffe K. Associations of lower extremity peripheral nerve impairment and risk of dementia in Black and White older adults. Neurology, 2022;98(18). Health ABC, 2,174 people. doi:10.1212/WNL.0000000000200185

13. Pinto JM, et al. 2017. NSHAP, 3,005 adults, five-year follow-up. pubmed.ncbi.nlm.nih.gov/28942611

14. Pinto JM, et al. Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One, 2014;9(10):e107541. NSHAP, 2,918 people. doi:10.1371/journal.pone.0107541

15. Lin FR, et al. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss (ACHIEVE). Lancet, 2023;402(10404):786-797. 977 people. doi:10.1016/S0140-6736(23)01406-X

16. ACHIEVE falls analysis, 2025. pubmed.ncbi.nlm.nih.gov/40441816

17. ACHIEVE social connection analysis, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12070280

18. ACHIEVE physical function analysis, 2026. pubmed.ncbi.nlm.nih.gov/42054408

19. Jiang F, et al. Association between hearing aid use and all-cause and cause-specific dementia: UK Biobank. Lancet Public Health, 2023;8(5):e329-e338. 437,704 people. doi:10.1016/S2468-2667(23)00048-8

20. Lee CS, et al. Association between cataract extraction and development of dementia. JAMA Intern Med, 2022;182(2):134-141. ACT, 3,038 people. doi:10.1001/jamainternmed.2021.6990

21. Sahi D, Overdevest J, Joseph PV. The Sensory Awareness Gap: Why Monitoring the Five Senses May Be the Missing Signal in Brain Health. In: A New Approach to Dementia (series, Tales A). Routledge, forthcoming.

22. Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature, 2022;604:697-707. 785 adults aged 51 to 81 scanned twice; 401 infected between scans. doi:10.1038/s41586-022-04569-5

23. GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050. Lancet Public Health, 2022;7(2):e105-e125. doi:10.1016/S2468-2667(21)00249-8

24. Maharani A, Dawes P, Nazroo J, Tampubolon G, Pendleton N. Cataract surgery and age-related cognitive decline: A 13-year follow-up of the English Longitudinal Study of Ageing. PLoS One. 2018;13(10):e0204833. doi:10.1371/journal.pone.0204833